CSF P-tau 231 as biomarker in alzheimer's disease

CSF P-tau 231 as biomarker in alzheimer's disease

Bibliographic Details
Main Authors:	Adreesh Mukherjee, Atanu Biswas
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-01-01
Series:	Annals of Indian Academy of Neurology
Online Access:	http://www.annalsofian.org/article.asp?issn=0972-2327;year=2022;volume=25;issue=6;spage=995;epage=996;aulast=Mukherjee

Similar Items

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
by: Niklas Mattsson, et al.
Published: (2017-07-01)

CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
by: Kristi Henjum, et al.
Published: (2018-11-01)

Plasma tau complements CSF tau and P‐tau in the diagnosis of Alzheimer's disease
by: Silvia Fossati, et al.
Published: (2019-12-01)

Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease.
by: Jere E Meredith, et al.
Published: (2013-01-01)

CSF p-Tau levels in the prediction of Alzheimer's disease
by: Ramesh J. L. Kandimalla, et al.
Published: (2013-09-01)

Evaluating p-tau217 and p-tau231 as Biomarkers for Early Diagnosis and Differentiation of Alzheimer’s Disease: A Narrative Review
by: Dorian Julian Jarek, et al.
Published: (2024-04-01)

Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
by: Rik Ossenkoppele, et al.
Published: (2021-07-01)

Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts
by: Juan Lantero-Rodriguez, et al.
Published: (2023-03-01)

CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status
by: Ruocheng Dong, et al.
Published: (2021-01-01)

The Relationship between p-tau217, p-tau231, and p-tau205 in the Human Brain Is Affected by the Cellular Environment and Alzheimer’s Disease Pathology
by: Malin Wennström, et al.
Published: (2024-02-01)

Fully synthetic phosphorylated Tau181, Tau217, and Tau231 calibrators for Alzheimer’s disease diagnosis
by: Xinyu Li, et al.
Published: (2024-01-01)

P-tau231 as a diagnostic biomarker for Alzheimer's Disease and mild cognitive impairment: A systematic review and meta-analysis
by: Fardin Nabizadeh, et al.
Published: (2022-01-01)

CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer’s disease
by: Qiang Qiang, et al.
Published: (2022-10-01)

Normalization of CSF pTau measurement by Aβ40 improves its performance as a biomarker of Alzheimer’s disease
by: Tengfei Guo, et al.
Published: (2020-08-01)

Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: disease staging by NF-L, p-tau181, and GFAP
by: Anna Lidia Wojdała, et al.
Published: (2023-12-01)

Sleep oscillation-specific associations with Alzheimer’s disease CSF biomarkers: novel roles for sleep spindles and tau
by: Korey Kam, et al.
Published: (2019-02-01)

Fluorescent Aptasensor and Colorimetric Aptablot for p-tau231 Detection: Toward Early Diagnosis of Alzheimer’s Disease
by: Le Minh Tu Phan, et al.
Published: (2022-01-01)

Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF
by: Brian D. Hitt, et al.
Published: (2021-05-01)

RETRACTED: CSF p-tau as a potential cognition impairment biomarker in ALS
by: Zhongying Gong, et al.
Published: (2022-11-01)

Retraction: CSF p-tau as a potential cognition impairment biomarker in ALS
by: Frontiers Editorial Office
Published: (2024-03-01)

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation
by: Kyu Hwan Shim, et al.
Published: (2020-07-01)

Gastrointestinal, respiratory, and olfactory neurotropism of Sars-Cov2 as a possible trigger of Parkinson's Disease: Is a multi-hit multi-step process on the cards
by: Amlan K Datta, et al.
Published: (2023-01-01)

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease
by: Nicolai Franzmeier, et al.
Published: (2024-01-01)

A Comparative Study of the Behavioral Profile of the Behavioral Variant of Frontotemporal Dementia and Parkinson’s Disease Dementia
by: Dinesh Saini, et al.
Published: (2020-12-01)

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
by: Delvenne, A, et al.
Published: (2024)

CSF metabolites associated with biomarkers of Alzheimer’s disease pathology
by: Ruocheng Dong, et al.
Published: (2023-08-01)

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
by: Shorena Janelidze, et al.
Published: (2020-04-01)

Female sex is linked to a stronger association between sTREM2 and CSF p-tau in Alzheimer’s disease
by: Davina Biel, et al.
Published: (2025-01-01)

Differential diagnosis of mild cognitive impairment of Alzheimer’s disease by Simoa p-tau181 measurements with matching plasma and CSF
by: Ling Wu, et al.
Published: (2024-01-01)

CSF and serum total-tau and phospho-tau(181P) in MS patients
by: Jaworski Jacek, et al.
Published: (2011-04-01)

Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
by: Sakulrat Mankhong, et al.
Published: (2022-04-01)

Effect of COVID-19 related lockdown on nonmotor symptoms of Parkinson's disease
by: Sourav Banerjee, et al.
Published: (2022-01-01)

P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
by: Juan Lantero‐Rodriguez, et al.
Published: (2021-11-01)

A novel plasma p-tau181 assay as a specific biomarker of tau pathology in Alzheimer's disease
by: Kenji Tagai, et al.
Published: (2024-09-01)

Correlation between Blood Monocytes and CSF Tau in Alzheimer’s Disease: The Effect of Gender and Cognitive Decline
by: Carlotta Ginevra Valentina Cimiotti, et al.
Published: (2023-12-01)

Post-Infective Rhombencephalitis with Bilateral Olivary Hypertrophic Degeneration
by: Amlan K. Datta, et al.
Published: (2024-04-01)

Association of CSF biomarkers with MRI brain changes in Alzheimer's disease
by: Nazib M Seidu, et al.
Published: (2024-01-01)

Variability of CSF Alzheimer's disease biomarkers: implications for clinical practice.
by: Stephanie J B Vos, et al.
Published: (2014-01-01)

T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease
by: Mohammad Haris, et al.
Published: (2015-01-01)

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
by: Rosha Babapour Mofrad, et al.
Published: (2019-12-01)